Physician profile
Robert Cymerman
NPI 1861416729
$2,035.54
in general payments reported to CMS, 2019-2025
10 companies · $1,371 in 2025
The $1,371 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $266 · 2022: $139 · 2023: $27.78 · 2024: $231 · 2025: $1,371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $630.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,281.85 | 2022-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $237.54 | 2025 | Assure Wcd |
| Abbott Laboratories | $170.60 | 2021-2022 | |
| Medtronic, INC. | $140.57 | 2024 | |
| Novo Nordisk INC | $120.00 | 2021 | |
| Atricure, INC. | $21.67 | 2024 | |
| Biosense Webster, INC. | $18.26 | 2025 | Carto 3 |
| Cvrx, INC. | $17.27 | 2022 | |
| Pfizer INC. | $14.03 | 2023 | |
| Amgen INC. | $13.75 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cymerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.